Gymnopoulos, M., Betancourt, O., Blot, V., Fujita, R., Galvan, D., Lieuw, V., . . . Coronella, J. (2019). TR1801‐ADC: A highly potent cMet antibody–drug conjugate with high activity in patient‐derived xenograft models of solid tumors. Mol Oncol.
Chicago-stil citatGymnopoulos, Marco, et al. "TR1801‐ADC: A Highly Potent CMet Antibody–drug Conjugate With High Activity in Patient‐derived Xenograft Models of Solid Tumors." Mol Oncol 2019.
MLA-referensGymnopoulos, Marco, et al. "TR1801‐ADC: A Highly Potent CMet Antibody–drug Conjugate With High Activity in Patient‐derived Xenograft Models of Solid Tumors." Mol Oncol 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.